Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000899243-22-010762

Director sold 65,725 shares at an average $7.48 ($491,850)

From the SEC's structured data for this filing

Trades in this filing

Hallal David · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-03-10 Sale : show line 1 in the form −40,481 $7.55 $305,781 2,173,085 D
2022-03-11 Sale : show line 2 in the form −25,244 $7.37 $186,068 2,147,841 D
Open-market sales · 65,725 sh · avg $7.48 · $491,850
Loading xslF345X03/doc4.xml…